首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmacopsychiatry

缩写:PHARMACOPSYCHIATRY

ISSN:0176-3679

e-ISSN:1439-0795

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引786
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Michael Specka,Udo Bonnet,Lisa Schmidberg et al. Michael Specka et al.
Background: There is a lack of studies on the course and effectiveness of medical cannabis in the treatment of major depressive disorder (MDD). Methods: ...
Matthias Karst Matthias Karst
Chronic pain is primarily conceptualized as a disease in its own right when it is associated with emotional distress and functional impairment. Pathophysiologically, dysfunction of the cortico-mesolimbic connectome is of major importance, w...
Julian Wellensiek,Michael Specka,Johannes Just et al. Julian Wellensiek et al.
Introduction: Pharmacotherapy with drugs like naltrexone or acamprosate is a well-evaluated element in the treatment of alcohol dependence (AD). However, in many countries, these medications are rarely administered. The o...
Peter Nyhuis,Dorothea Mücke,Michael Specka et al. Peter Nyhuis et al.
Objective: Studies have demonstrated the efficacy of injectable caffeine as an augmentation method in electroconvulsive therapy (ECT). This study investigated whether orally administered caffeine increases seizure duratio...
Sigrid Breit,Agnes Meyer,Wolfgang Schmitt et al. Sigrid Breit et al.
Introduction: Electroconvulsive therapy (ECT) is known to be effective in the treatment of catatonia, reaching response rates of about 80 to 100%. It is indicated in cases of treatment resistance to benzodiazepines and in...
Juliane K Mueller,Kira F Ahrens,Michael Bauer et al. Juliane K Mueller et al.
Introduction: In patients with a pre-existing mental disorder, an increased risk for a first manifestation of a psychiatric disorder in COVID-19 patients, a more severe course of COVID-19 and an increased mortality have b...
Garrett D Alexander,Luke R Cavanah,Jessica L Goldhirsh et al. Garrett D Alexander et al.
Introduction: There has been a pronounced increase in the use of Schedule II stimulants to treat attention-deficit hyperactivity disorder (ADHD) in the United States over the last two decades. Interestingly, chronic medic...
Kengo Yonezawa,Hiroyuki Uchida,Taisuke Yatomi et al. Kengo Yonezawa et al.
Introduction: Predictors of treatment response to intravenous ketamine remain unclear in patients with treatment-resistant depression (TRD); therefore, this study aimed to clarify these predictors using the US National In...
Vincent Eggart,Matin Mortazavi,Sophie-Kathrin Kirchner et al. Vincent Eggart et al.
Background: Non-suicidal self-injury (NSSI) behaviour is frequently observed in children and adolescents with psychiatric conditions. Affected individuals are regularly treated with psychotropic drugs, although the impact...